Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Aptevo Therapeutics Inc (NASDAQ: APVO) was $1.2 for the day, down -3.23% from the previous closing price of $1.24. In other words, the price has decreased by -$3.23 from its previous closing price. On the day, 8.18 million shares were traded. APVO stock price reached its highest trading level at $1.29 during the session, while it also had its lowest trading level at $1.15.
Ratios:
Our analysis of APVO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.03. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 10 ’25 when Grant Grady III bought 13,513 shares for $1.49 per share. The transaction valued at 20,134 led to the insider holds 13,514 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 20220594 and an Enterprise Value of 3949592.
Stock Price History:
The Beta on a monthly basis for APVO is 1.42, which has changed by -0.98898757 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, APVO has reached a high of $298.00, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -16.36%, while the 200-Day Moving Average is calculated to be -88.16%.
Shares Statistics:
APVO traded an average of 5.87M shares per day over the past three months and 636320 shares per day over the past ten days. A total of 16.85M shares are outstanding, with a floating share count of 16.83M. Insiders hold about 0.10% of the company’s shares, while institutions hold 7.19% stake in the company. Shares short for APVO as of 1764288000 were 391017 with a Short Ratio of 0.07, compared to 1761868800 on 501240. Therefore, it implies a Short% of Shares Outstanding of 391017 and a Short% of Float of 2.32.
Earnings Estimates
. The current assessment of Aptevo Therapeutics Inc (APVO) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.
Analysts are recommending an EPS of between -$5.38 and -$5.38 for the fiscal current year, implying an average EPS of -$5.38. EPS for the following year is -$1.6, with 1.0 analysts recommending between -$1.6 and -$1.6.
